Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: REGN5381 · Heart Failure With Reduced Ejection Fraction Results posted: Nov 19, 2026 Regeneron PharmaceuticalsPhase 2 NCT06237309
  2. Notable: Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells · Multiple Myeloma Undergoing Autologous Stem Cell Transplant Results posted: Nov 19, 2026 GPCR Therapeutics, Inc.Phase 2 NCT05561751
  3. Notable: Oral ZL-65 Tablets in Healthy and Obese · Cardiovascular Risk Eligibility criteria changed Chengdu Zenitar Biomedical Technology Co., LtdPhase 1 NCT07946783
  4. Notable: ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration Start date pushed from Jul 13, 2018 to Jan 30, 2019 Astellas Institute for Regenerative MedicinePhase 1 NCT03178149
  5. Notable: Performance of the Next-Generation SAFESYNC Transcatheter Heart Valve · Severe Aortic Stenosis Enrollment increased: 40 → 210 participants Braile Biomedica Ind. Com. e Repr. Ltda.Not applicable NCT07806409
  6. Notable: Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin Eligibility criteria changed National Institute on Aging (NIA)Phase 2 NCT07721467
  7. Notable: Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers Start date pushed from Nov 23, 2026 to Jan 19, 2027 National Cancer Institute (NCI)Phase 2 NCT07686367
  8. Notable: Baricitinib · Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis Eligibility criteria changed National Institute of Allergy and Infectious Diseases (NIAID)Phase 1 NCT07262983
  9. Notable: H1ssF-3928 mRNA-LNP in Healthy Adults Results posted: Nov 19, 2026 National Institute of Allergy and Infectious Diseases (NIAID)Phase 1 NCT05755620
  10. Notable: FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps Start date pushed from Oct 15, 2026 to Jan 15, 2027 Services Institute of Medical Sciences, PakistanNot applicable NCT07855315
  11. Notable: Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial Results posted: Nov 19, 2026 Jason SperryPhase 3 NCT04684719
  12. Notable: EFFET - Study of Executive Functions Regarding the Usability and User Experience of Assistive Technologies Among the Elderly Start date pushed from Oct 1, 2026 to Jan 15, 2027 University Hospital, AngersNot applicable NCT07834775
  13. Notable: High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) Primary completion date changed from estimate of Sep 30, 2021 to Jan 30, 2025 St. Anna KinderkrebsforschungPhase 3 NCT01704716
  14. Notable: Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study Results posted: Nov 19, 2026 Fred Hutchinson Cancer CenterPhase 3 NCT04447313
  15. Notable: CEUS Evaluation of Hydrocephalus in Neonates and Infants Start date pushed from Nov 30, 2026 to Dec 30, 2026 Children's Hospital of PhiladelphiaPhase 2 NCT06693752
  16. Notable: PEP-CMV Vaccine Targeting CMV Antigen · Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma Eligibility criteria changed Nationwide Children's HospitalPhase 2 NCT05096481
  17. Notable: MRI Study of OnabotulinumtoxinA (OnabotA) Effect on Jaw Muscle Pain Start date pushed from Oct 2026 to Dec 1, 2026 Weill Medical College of Cornell UniversityPhase 2 NCT07878780
  18. Notable: Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile® Start date pushed from Oct 2026 to Dec 2026 University of California, IrvinePhase 2 NCT07821112
  19. Notable: Rectus Sheath Block for Analgesia After Gynecological Laparotomy Results posted: Nov 19, 2026 Duke UniversityPhase 4 NCT06575699
  20. Notable: Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas Enrollment increased: 39 → 84 participants NYU Langone HealthEarly Phase 1 NCT06829173
  21. Notable: Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer Primary completion moved earlier from Jul 31, 2030 to Jul 31, 2028 National Taiwan University HospitalNot specified NCT03789253
  22. Notable: Qi Gong Program on Dissociative Symptoms · Experienced Childhood Trauma Start date pushed from Sep 2026 to Dec 2026 Centre Hospitalier Universitaire de la RéunionNot applicable NCT07670663
  23. Notable: Acute Myocardial Infarction in Cancer Patients Study completion date changed from estimate of Dec 31, 2025 to Nov 17, 2026 Samsung Medical CenterNot specified NCT06281054
  24. Notable: Predictive Algorithms for Critical Rehabilitation Outcomes Enrollment increased: 250 → 390 participants Wuhan UniversityNot specified NCT06532994
  25. Notable: COG+OT Telerehabilitation · Subjective Cognitive Complaints Start date pushed from Nov 1, 2026 to Dec 2026 Medical University of South CarolinaNot applicable NCT07743229